Preferred Label : phenylpropionates;
MeSH definition : Derivatives of 3-phenylpropionic acid, including its salts and esters.;
Is substance : O;
Origin ID : D010666;
UMLS CUI : C0031497;
Allowable qualifiers
Record concept(s)
Related MeSH Supplementary Concept(s)
- AMG-837 [MeSH Supplementary Concept]
- ARN2508 [MeSH Supplementary Concept]
- BU10038 [MeSH Supplementary Concept]
- CH1055 [MeSH Supplementary Concept]
- CO 068 [MeSH Supplementary Concept]
- KY02111 [MeSH Supplementary Concept]
- NA 255 [MeSH Supplementary Concept]
- TUG-469 [MeSH Supplementary Concept]
- U 77864 [MeSH Supplementary Concept]
- aprofen [MeSH Supplementary Concept]
- fenozan [MeSH Supplementary Concept]
- venusol [MeSH Supplementary Concept]
Semantic type(s)
Derivatives of 3-phenylpropionic acid, including its salts and esters.
https://www.has-sante.fr/jcms/p_3169251/fr/ambrisentan-reddy-pharma
2020
false
false
false
France
drugs, generic
ambrisentan
evaluation of the transparency committee
ambrisentan
phenylpropionates
pyridazines
---
https://www.has-sante.fr/jcms/p_3185845/fr/ambrisentan-teva
2020
false
false
false
France
drugs, generic
ambrisentan
evaluation of the transparency committee
ambrisentan
phenylpropionates
pyridazines
---
https://www.has-sante.fr/jcms/p_3184674/fr/ambrisentan-mylan
2020
false
false
false
France
drugs, generic
ambrisentan
evaluation of the transparency committee
ambrisentan
phenylpropionates
pyridazines
phenylpropionates
pyridazines
---
https://www.has-sante.fr/jcms/p_3191481/fr/ambrisentan-ohre-pharma
2020
false
false
false
France
drugs, generic
ambrisentan
evaluation of the transparency committee
ambrisentan
phenylpropionates
pyridazines
phenylpropionates
pyridazines
---
https://www.has-sante.fr/jcms/p_3135595/fr/ambrisentan-accord
2019
false
false
false
France
French
drugs, generic
evaluation of the transparency committee
ambrisentan
ambrisentan
Perianal abscess
generations
dandruff
devices
tablets
family characteristics
Brain abscess
device, nos
Set, Psychology
seborrhea sicca
dandruff
equipment and supplies
phenylpropionates
pyridazines
phenylpropionates
pyridazines
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ambrisentan-mylan
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drugs, generic
ambrisentan
ambrisentan
antihypertensive agents
antihypertensive agents
ambrisentan
hypertension, pulmonary
adult
drug therapy, combination
administration, oral
Endothelin A Receptor Antagonists
Endothelin A Receptor Antagonists
aged
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical
phenylpropionates
pyridazines
phenylpropionates
pyridazines
---
http://www.has-sante.fr/portail/jcms/c_2751870/fr/volibris
https://www.has-sante.fr/portail/jcms/c_2751870/fr/volibris-ambrisentan-antihypertenseur
2017
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
drug therapy, combination
treatment outcome
hypertension, pulmonary
ambrisentan
ambrisentan
adult
Tadalafil
administration, oral
orphan drug production
ambrisentan
phenylpropionates
pyridazines
phenylpropionates
pyridazines
phenylpropionates
pyridazines
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=152637&nom=Acide+hydrocinnamique
Canada
French
phenylpropionates
3-phenylpropionic acid
toxicological data sheet
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=779538&nom=Acide+hydroxy-4+benzène+propanoïque
Canada
French
phenylpropionates
phloretic acid
toxicological data sheet
---
https://www.ema.europa.eu/medicines/human/EPAR/Volibris
2012
false
United Kingdom
English
French
Endothelin A Receptor Antagonists
Endothelin A Receptor Antagonists
syndication feed
ambrisentan
ambrisentan
phenylpropionates
pyridazines
pyridazines
drug approval
drug labeling
treatment outcome
drug evaluation
orphan drug production
tablets
administration, oral
hypertension, pulmonary
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
phenylpropionates
ambrisentan
drug evaluation
summary of product characteristics
package leaflet
---